Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2006-02-07
2006-02-07
Harris, Alana M. (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S130100, C424S138100, C424S154100, C424S155100, C424S156100, C424S277100, C424S093700, C530S387300, C530S388850
Reexamination Certificate
active
06994853
ABSTRACT:
The invention relates to the time-staggered utilization of tumor cells in combination with intact, preferably heterologous antibodies for the immunization of humans and animals.
REFERENCES:
patent: 5837248 (1998-11-01), Kikuchi et al.
patent: 5985276 (1999-11-01), Lindhofer et al.
patent: 6235785 (2001-05-01), Jedlitschky et al.
patent: 6458369 (2002-10-01), Berd
patent: 6551592 (2003-04-01), Lindhofer et al.
patent: 19710497 (1998-03-01), None
patent: 0885614 (1998-12-01), None
Lindhofer et al, Annual meeting international society for experimental hematology XX, XX, 1997, 25:879, abstract 527.
Multihoff et al (Int. J. Cancer 61:272-279, 1995).
Campbell et al., “The role of tumor rejection antigens in host antitumor defense mechanisms,”Cancer(1995) 75(11): 2649-55.
Lindhofer et al., “Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models,”Blood1996) 88(2): 4651-58.
Lindhofer et al., “Bispecific antibodies effectively purge cancer cells from peripheral blood stem cell collections without affecting colony forming units,” Annual Meeting International Society for Experimental Hematology, XX, XX (1997) 25(8): 879.
Lindhofer Horst
Ruf Peter
Harris Alana M.
Holleran Anne L.
Townsend and Townsend / and Crew LLP
Trion Pharma GmbH
LandOfFree
Time-staggered utilization of tumor cells in combination... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Time-staggered utilization of tumor cells in combination..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Time-staggered utilization of tumor cells in combination... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3647745